{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:49:55Z","timestamp":1788929395566,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K19559"],"award-info":[{"award-number":["21K19559"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.anl.2022.07.005","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T01:13:57Z","timestamp":1659662037000},"page":"171-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intractable otitis media - Pathogenesis and treatment of Eosinophilic otitis media (EOM) and otitis media with Antineutrophil cytoplasmic antibody (ANCA) -associated vasculitis (OMAAV)"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0933-7470","authenticated-orcid":false,"given":"Naohiro","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2022.07.005_bib0001","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.anl.2020.05.019","article-title":"Clinical practice guidelines for the diagnosis and management of acute otitis media in children\u20142018 update","volume":"47","author":"Hayashi","year":"2020","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.07.005_bib0002","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.anl.2017.03.018","article-title":"Clinical practice guidelines for the diagnosis and management of otitis media with effusion (OME) in children in Japan","volume":"44","author":"Ito","year":"2017","journal-title":"2015 Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.07.005_bib0003","first-page":"282","article-title":"Algorithm of diagnosis for otitis media associated with ANCA vasculitis (OMAAV)","volume":"23","author":"Iino","year":"2013","journal-title":"Otol Jpn"},{"key":"10.1016\/j.anl.2022.07.005_bib0004","series-title":"Proceedings of the Second Extraordinary International Symposium in Recent Advances on Otitis Media","first-page":"183","article-title":"Intractable otitis media in cases with bronchial asthma. Recent advances in otitis media with effusion","volume":"6","author":"Tomioka","year":"1994"},{"issue":"2","key":"10.1016\/j.anl.2022.07.005_bib0005","first-page":"112","article-title":"Epidemiologic surveillance of \"Eosinophilic Otitis Media\" in Japan","volume":"14","author":"Suzuki","year":"2004","journal-title":"Otol Jpn"},{"key":"10.1016\/j.anl.2022.07.005_bib0006","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.anl.2010.11.016","article-title":"Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease","volume":"38","author":"Iino","year":"2011","journal-title":"Auris Nasus Larynx"},{"issue":"6","key":"10.1016\/j.anl.2022.07.005_bib0007","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1097\/MAO.0000000000000369","article-title":"Eosinophilic otitis media","volume":"35","author":"Childers","year":"2014","journal-title":"Otol Neurotol"},{"issue":"7","key":"10.1016\/j.anl.2022.07.005_bib0008","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1056\/NEJMicm1510852","article-title":"Eosinophilic Otitis Media","volume":"376","author":"Lara-S\u00e1nchez","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2022.07.005_bib0009","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1046\/j.1365-2222.2001.01134.x","article-title":"Eosinophils are activated in middle ear mucosa and middle ear effusion of patients with intractable otitis media associated with bronchial asthma","volume":"31","author":"Iino","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anl.2022.07.005_bib0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/0036554021000028117","article-title":"IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion","volume":"123","author":"Nonaka","year":"2003","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.anl.2022.07.005_bib0011","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/j.1365-2222.2005.02330.x","article-title":"Eosinophil chemoattractant in middle ear patients with eosinophilic otitis me- dia","volume":"35","author":"Iino","year":"2005","journal-title":"Clin Exp Allergy"},{"issue":"Suppl","key":"10.1016\/j.anl.2022.07.005_bib0012","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.alit.2015.03.007","article-title":"Eosinophil-derived neurotoxin, elastase, and cytokine profile in effusion from eosinophilic otitis media","volume":"64","author":"Uchimizu","year":"2015","journal-title":"Allergol Int"},{"key":"10.1016\/j.anl.2022.07.005_bib0013","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.anai.2014.04.021","article-title":"Antigen-specific IgE in middle ear effusion of patients with eosinophilic otitis media","volume":"113","author":"Kanazawa","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anl.2022.07.005_bib0014","first-page":"353","article-title":"Risk factors for eosinophilic otitis media in patients with eosinophilic chronic rhinosinusitis","volume":"9","author":"Kanazawa","year":"2013","journal-title":"Int Adv Otol"},{"key":"10.1016\/j.anl.2022.07.005_bib0015","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1001\/archotol.132.10.1109","article-title":"Eustachian tube function in patients with eosinophilic otitis media associated with bronchial asthma evaluated by sonotubometry","volume":"132","author":"Iino","year":"2006","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"10","key":"10.1016\/j.anl.2022.07.005_bib0016","doi-asserted-by":"crossref","first-page":"E2689","DOI":"10.1002\/lary.29671","article-title":"Anatomical features around eustachian tube in eosinophilic otitis media with eosinophilic sinusitis","volume":"131","author":"Ohira","year":"2021","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.anl.2022.07.005_bib0017","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaci.2015.04.041","article-title":"Eosinophil extracellular trap cell death-derived DNA traps: their presence in secretions and functional attributes","volume":"137","author":"Ueki","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anl.2022.07.005_bib0018","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11882-017-0702-5","article-title":"Eosinophilic otitis media: the aftermath of eosinophil extracellular trap cell death","volume":"17","author":"Ueki","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"10.1016\/j.anl.2022.07.005_bib0019","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.alit.2017.11.007","article-title":"ETosis-derived DNA trap production in middle ear effusion is a common feature of eosinophilic otitis media","volume":"67","author":"Ohta","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.anl.2022.07.005_bib0020","article-title":"The Quantification of extracellular trap cell death-derived products as diagnostic biomarkers for otitis media with antineutrophil cytoplasmic antibody-associated vasculitis and eosinophilic otitis media","author":"Morita","year":"2021","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2022.07.005_bib0021","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2332\/allergolint.13-RAI-0663","article-title":"Periostin in allergic inflammation","volume":"63","author":"Izuhara","year":"2014","journal-title":"Allergol Int"},{"issue":"2","key":"10.1016\/j.anl.2022.07.005_bib0022","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2332\/allergolint.13-RAI-0673","article-title":"Expressions and roles of periostin in otolaryngological diseases","volume":"63","author":"Ohta","year":"2014","journal-title":"Allergol Int"},{"issue":"8","key":"10.1016\/j.anl.2022.07.005_bib0023","first-page":"838","article-title":"The role of periostin in eosinophilic otitis media","volume":"132","author":"Nishizawa","year":"2012","journal-title":"Acta Otolaryngol"},{"issue":"4","key":"10.1016\/j.anl.2022.07.005_bib0024","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.anl.2020.05.014","article-title":"Periostin in middle ear mucosa according to eosinophilic otitis media severity: middle ear pathology-based treatment","volume":"47","author":"Esu","year":"2020","journal-title":"Auris Nasus Larynx"},{"issue":"3","key":"10.1016\/j.anl.2022.07.005_bib0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/00016489.2013.859395","article-title":"An experimental study of inner ear injury in an animal model of eosinophilic otitis media","volume":"134","author":"Matsubara","year":"2014","journal-title":"Acta Otolaryngol"},{"issue":"5","key":"10.1016\/j.anl.2022.07.005_bib0026","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/00016489.2016.1266508","article-title":"Immunohistological analysis of eotaxin and RANTES in the model animal of eosinophilic otitis media","volume":"137","author":"Kudo","year":"2017","journal-title":"Acta Otolaryngol"},{"issue":"7","key":"10.1016\/j.anl.2022.07.005_bib0027","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/MAO.0b013e318263d5b8","article-title":"Clinical efficacy of anti-IgE therapy for eosinophilic otitis media","volume":"33","author":"Iino","year":"2012","journal-title":"Otol Neurotol"},{"issue":"8","key":"10.1016\/j.anl.2022.07.005_bib0028","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1097\/MAO.0000000000001912","article-title":"Proposal of a treatment strategy for eosinophilic otitis media based on middle ear condition","volume":"39","author":"Esu","year":"2018","journal-title":"Otol Neurotol"},{"issue":"3","key":"10.1016\/j.anl.2022.07.005_bib0029","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4168\/aair.2013.5.3.175","article-title":"Improvement of eosinophilic otitis media by optimized asthma treatment","volume":"5","author":"Tanaka","year":"2013","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"10.1016\/j.anl.2022.07.005_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000370122","article-title":"Eosinophilic otitis media is associated with asthma severity and smoking history","volume":"77","author":"Seo","year":"2015","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"1","key":"10.1016\/j.anl.2022.07.005_bib0031","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.5415\/apallergy.2018.8.e5","article-title":"Optimal control of asthma improved eosinophilic otitis media","volume":"8","author":"Seo","year":"2018","journal-title":"Asia Pac Allergy"},{"issue":"1","key":"10.1016\/j.anl.2022.07.005_bib0032","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/ACI.0000000000000589","article-title":"Eosinophilic otitis media and comorbid asthma","volume":"20","author":"Seo","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anl.2022.07.005_bib0033","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.anl.2020.08.001","article-title":"Risk factors for bacterial infection tocause sensorineural hearing loss in eosinophilic otitis media","volume":"48","author":"Masuda","year":"2021","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.07.005_bib0034","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1398-9995.2000.00090.x","article-title":"Survey of recognition and utilization of guidelines for the diagnosis and management of bronchial asthma in Japan","volume":"55","author":"Makino","year":"2000","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anl.2022.07.005_bib0035","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.anl.2014.08.003","article-title":"Risk factors associated with severity of eosinophilic otitis media","volume":"41","author":"Kanazawa","year":"2014","journal-title":"Auris Nasus Larynx"},{"issue":"12","key":"10.1016\/j.anl.2022.07.005_bib0036","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11882-015-0577-2","article-title":"New insights into eosinophilic otitis media","volume":"15","author":"Kanazawa","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"10.1016\/j.anl.2022.07.005_bib0037","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.anl.2020.09.005","article-title":"Effectiveness of myringoplasty in patients with eosinophilic otitis media","volume":"48","author":"Esu","year":"2021","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.07.005_bib0038","series-title":"Recent advances in otitis media","first-page":"403","article-title":"The effect of topical administration of heparin to the eosinophilic otitis media","author":"Matsubara","year":"2001"},{"issue":"5","key":"10.1016\/j.anl.2022.07.005_bib0039","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/1744666X.2017.1298443","article-title":"Commonality of the IL-4\/IL-13 pathway in atopic diseases","volume":"13","author":"Gandhi","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"10.1016\/j.anl.2022.07.005_bib0040","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3109\/00016489.2013.868601","article-title":"Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media","volume":"134","author":"Iino","year":"2014","journal-title":"Acta Otolaryngol"},{"issue":"2","key":"10.1016\/j.anl.2022.07.005_bib0041","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.anl.2018.07.011","article-title":"Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media","volume":"46","author":"Iino","year":"2019","journal-title":"Auris Nasus Larynx"},{"issue":"1","key":"10.1016\/j.anl.2022.07.005_bib0042","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.anl.2018.05.007","article-title":"Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab","volume":"46","author":"Suzaki","year":"2019","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.07.005_bib0043","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1097\/MAO.0000000000002493","article-title":"Use of IL-5 inhibitor benralizumab as a novel therapy for eosinophilic otitis media: clinical capsule and review of literature","author":"Chow","year":"2020","journal-title":"Otol Neurotol"},{"issue":"20","key":"10.1016\/j.anl.2022.07.005_bib0044","doi-asserted-by":"crossref","first-page":"11209","DOI":"10.3390\/ijms222011209","article-title":"IL13 May play an important role in developing eosinophilic chronic rhinosinusitis and eosinophilic otitis media with severe asthma","volume":"22","author":"Shimizu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anl.2022.07.005_bib0045","article-title":"Successful treatment of eosinophilic chronic rhinosinusitis and eosinophilic otitis media using the anti-IL-5 receptor monoclonal antibody benralizumab: a case report","volume":"30","author":"Kagoshima","year":"2020","journal-title":"Respir Med Case Rep"},{"issue":"3","key":"10.1016\/j.anl.2022.07.005_bib0046","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.alit.2021.02.002","article-title":"Cycling therapy with benralizumab and dupilumab for severe eosinophilic asthma with eosinophilic chronic rhinosinusitis and eosinophilic otitis media","volume":"70","author":"Hamada","year":"2021","journal-title":"Allergol Int"},{"issue":"12","key":"10.1016\/j.anl.2022.07.005_bib0047","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/lary.29730","article-title":"Complete Remission of Severe Eosinophilic Otitis Media With Dupilumab: A Case Report","volume":"131","author":"van der Lans","year":"2021","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1016\/j.anl.2022.07.005_bib0048","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.anl.2020.09.001","article-title":"Dupilumab therapy for patients with refractory eosinophilic otitis media associated with bronchial asthma","volume":"48","author":"Iino","year":"2021","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.07.005_bib0049","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bmj.285.6342.606","article-title":"Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?","volume":"285","author":"Davies","year":"1982","journal-title":"Br Med J"},{"key":"10.1016\/j.anl.2022.07.005_bib0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","article-title":"Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis","volume":"1","author":"van der Woude","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.anl.2022.07.005_bib0051","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11926-013-0363-x","article-title":"Biomarkers in ANCA-associated vasculitis","volume":"15","author":"Lally","year":"2013","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.anl.2022.07.005_bib0053","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","article-title":"Pathogenesis and therapeutic interventions for ANCA-associated vasculitis","volume":"15","author":"Nakazawa","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.anl.2022.07.005_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised international chapel hill conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anl.2022.07.005_bib0054","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","article-title":"Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years","volume":"98","author":"Fauci","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.anl.2022.07.005_bib0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2273.1989.tb00403.x","article-title":"Ear involvement in Wegener's granulomatosis","volume":"14","author":"Kempt","year":"1989","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"10.1016\/j.anl.2022.07.005_bib0056","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/MAO.0b013e31822558fd","article-title":"Otologic symptoms as initial manifestation of Wegener granulomatosis: diagnostic dilemma","volume":"32","author":"Wierzbicka","year":"2011","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2022.07.005_bib0057","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.anl.2022.07.005_bib0058","first-page":"1","article-title":"Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): A retrospective analysis of 235 patients from a nationwide survey in Japan","volume":"11","author":"Harabuchi","year":"2016","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.anl.2022.07.005_bib0059","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2332\/allergolint.14-RAI-0774","article-title":"Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis","volume":"63","author":"Yoshida","year":"2014","journal-title":"Allergol Int"},{"issue":"1","key":"10.1016\/j.anl.2022.07.005_bib0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.anl.2020.07.004","article-title":"Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society","volume":"48","author":"Harabuchi","year":"2021","journal-title":"Auris Nasus Larynx"},{"issue":"5","key":"10.1016\/j.anl.2022.07.005_bib0061","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.anl.2020.02.017","article-title":"Tympanic membrane findings of otitis media with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV)","volume":"47","author":"Morita","year":"2020","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.07.005_bib0062","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/MAO.0b013e31822558fd","article-title":"Otologic symptoms as initial manifestation of wegener granulomatosis: diagnostic dilemma","volume":"32","author":"Wierzbicka","year":"2011","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2022.07.005_bib0063","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/000348940411300509","article-title":"Clinical features of bilateral progressive hearing loss associated with myeloperoxidase-antineutrophil cytoplasmic antibody","volume":"113","author":"Takagi","year":"2004","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.anl.2022.07.005_bib0064","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.anl.2007.01.005","article-title":"Early diagnosis of Wegener's granulomatosis presenting with bilateral facial paralysis and bilateral serous otitis media","volume":"34","author":"Ferri","year":"2007","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.07.005_bib0065","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00296-006-0213-5","article-title":"The occurrence of sensorineural hearing loss in a patient with myeloperoxidase-anti-neutrophil cytoplasmic antibody-related microscopic polyangiitis","volume":"27","author":"Sugimoto","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.anl.2022.07.005_bib0066","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3342\/ceo.2011.4.3.155","article-title":"Reversible sensorineural hearing loss due to pachymeningitis associated with elevated serum MPO-ANCA","volume":"4","author":"Lim","year":"2011","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"10.1016\/j.anl.2022.07.005_bib0067","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.anl.2011.03.010","article-title":"Reversible cochlear disorders with normal vestibular functions in three cases with Wegener's granulomatosis","volume":"39","author":"Yamazaki","year":"2012","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.07.005_bib0068","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1044\/1059-0889(2012\/12-0003)","article-title":"Early intervention in localized Wegener's granulomatosis with sensorineural hearing loss preserves hearing","volume":"21","author":"Sriskandarajah","year":"2012","journal-title":"Am J Audiol"},{"key":"10.1016\/j.anl.2022.07.005_bib0069","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MAO.0000000000000175","article-title":"Reversible cochlear function with ANCA-associated vasculitis initially diagnosed by otologic symptoms","volume":"35","author":"Yoshida","year":"2014","journal-title":"Otol Neurotol"},{"issue":"5","key":"10.1016\/j.anl.2022.07.005_bib0070","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.anl.2017.12.007","article-title":"Cochlear implantation in patients with bilateral deafness caused by otitis media with ANCA-associated vasculitis (OMAAV): A report of four cases","volume":"45","author":"Watanabe","year":"2018","journal-title":"Auris Nasus Larynx"},{"issue":"2","key":"10.1016\/j.anl.2022.07.005_bib0071","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1097\/MAO.0000000000002081","article-title":"The diagnostic and clinical utility of the myeloperoxidase-DNA complex as a biomarker in otitis media with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"40","author":"Morita","year":"2019","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2022.07.005_bib0052","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small and medium vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.anl.2022.07.005_bib0073","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1097\/MAO.0000000000001563","article-title":"Comparison of localized and systemic otitis media with ANCA-associated vasculitis","volume":"38","author":"Okada","year":"2017","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2022.07.005_bib0074","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.anl.2018.05.011","article-title":"The treatment outcomes of rituximab for intractable otitis media with ANCA-associated vasculitis","volume":"46","author":"Okada","year":"2019","journal-title":"Auris Nasus Larynx"},{"issue":"3","key":"10.1016\/j.anl.2022.07.005_bib0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.anl.2020.09.004","article-title":"The hearing prognosis of otitis media with ANCA-associated vasculitis","volume":"48","author":"Iwata","year":"2021","journal-title":"Auris Nasus Larynx"},{"issue":"9","key":"10.1016\/j.anl.2022.07.005_bib0076","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.anl.2022.07.005_bib0078","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/14712598.2020.1748597","article-title":"Rituximab treatment of ANCA-associated vasculitis","volume":"20","author":"Raffray","year":"2020","journal-title":"Expert Opin Biol Ther"},{"issue":"8","key":"10.1016\/j.anl.2022.07.005_bib0077","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.anl.2022.07.005_bib0079","first-page":"59","article-title":"Serum levels of soluble interleukin-2 receptor in patients with ANCA-associated vasculitis","volume":"13","author":"Arranz","year":"2000","journal-title":"J Nephrol"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814622001912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814622001912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:39:06Z","timestamp":1759952346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814622001912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0385814622001912"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2022.07.005","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intractable otitis media - Pathogenesis and treatment of Eosinophilic otitis media (EOM) and otitis media with Antineutrophil cytoplasmic antibody (ANCA) -associated vasculitis (OMAAV)","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2022.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}